加载中
NYSEHealthcareMedical - Care Facilities
最新数据
US$3.52
−US$0.36 · -9.28%
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
常规交易时段
US$3.52
−US$0.36 · -9.28%
盘中时间采用ET。市场数据可能有所延迟。
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
日内区间
当前US$3.52
52周区间
当前US$3.52
盘中时间采用ET。市场数据可能有所延迟。
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
日内区间
当前US$3.52
52周区间
当前US$3.52
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 4.61亿 CNY | 3.84亿 CNY | 5.37亿 CNY | 4.72亿 CNY | 4.86亿 CNY |
| 销货成本 | 4.35亿 CNY | 4.63亿 CNY | 6.14亿 CNY | 6.24亿 CNY | 5.43亿 CNY |
| 毛利 | 2581.9万 CNY | −7916.2万 CNY | −7660.8万 CNY | −1.52亿 CNY | −5689.7万 CNY |
| 销售、一般及管理费用 | 2.65亿 CNY | 4.53亿 CNY | 3.86亿 CNY | 3.73亿 CNY | 4.01亿 CNY |
| 营业费用 | 2.65亿 CNY | 4.53亿 CNY | 3.86亿 CNY | 3.73亿 CNY | 4.01亿 CNY |
| 利息收入 | 968.4万 CNY | 1398.2万 CNY | 1083.2万 CNY | 1002.1万 CNY | 589.4万 CNY |
| 利息支出 | 1.52亿 CNY | 1.93亿 CNY | 1.66亿 CNY | 1.2亿 CNY | 7378.9万 CNY |
| 折旧和摊销 | 1.49亿 CNY | 1.31亿 CNY | 1.28亿 CNY | 1.33亿 CNY | 1.04亿 CNY |
| 营业利润 | −2.39亿 CNY | −5.32亿 CNY | −4.63亿 CNY | −5.25亿 CNY | −4.58亿 CNY |
| 净利润 | −9281.1万 CNY | −3.08亿 CNY | −2.98亿 CNY | −4.9亿 CNY | −2.71亿 CNY |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
US$0.99
2015年（完整年度）+526.1% 自从 2011
US$0.1581
2,011
US$8.71
2,014
US$0.99
2,015
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2015年12月23日 | US$0.99Special | 2015年12月28日 | 2016年1月29日 |
股息 | 2014年8月5日 | US$0.90Special | 2014年8月7日 | 2014年9月30日 |
股息 | 2014年1月16日 | US$0.71Annual | 2014年1月21日 | 2014年1月30日 |
股息 | 2014年1月16日 | US$0.72Special | 2014年1月21日 | 2014年1月30日 |
股息 | 2011年8月29日 | US$0.18Special | 2011年8月31日 | 2011年9月30日 |
除息 2015年12月23日
US$0.99
Special
2015年12月28日登记 · 支付日 2016年1月29日
除息 2014年8月5日
US$0.90
Special
2014年8月7日登记 · 支付日 2014年9月30日
除息 2014年1月16日
US$0.71
Annual
2014年1月21日登记 · 支付日 2014年1月30日
除息 2014年1月16日
US$0.72
Special
2014年1月21日登记 · 支付日 2014年1月30日
除息 2011年8月29日
US$0.18
Special
2011年8月31日登记 · 支付日 2011年9月30日
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
